Navigation Links
UCB Announces Positive Results From Phase II Clinical Trial of Investigational Anti-Epilepsy Drug Brivaracetam
Date:12/3/2007

55.8% of patients, for 5mg/day, 20mg/day and 50mg/day, respectively,

compared to 16.7% for placebo.

-- Produced seizure freedom rates of 7.7% for 20 mg-50 mg/day, 8% for

5mg/day and 1.9% for placebo over the treatment period.

Patients in the second study (Abstract 3.218) were randomized to receive 50 mg/day, 150 mg/day, or placebo, administered twice-daily without titration over the 12 week treatment period. The findings for the study's primary endpoint-reduction in weekly seizure frequency over placebo-were not statistically significant. However, an analysis of the study's secondary endpoints demonstrated a clear difference between placebo and the 50 mg/day dose:
-- The median difference versus placebo for the percent reduction from

baseline in seizure frequency per week was 22.5%.

-- There was at least a 50% reduction in weekly seizure frequency from

baseline in 39.6% of patients, compared with 23.1% for placebo.

-- Seizure freedom rates of 9.4% were seen for 50mg/day, compared with

1.9% for placebo.

Retention rates in both studies were high and similar to placebo, with up to 98% of patients in the treatment group completing the studies. The most commonly reported adverse events were nausea, vomiting, fatigue, nasopharyngitis, anorexia, convulsion, dizziness, headache, somnolence, and insomnia. A dose-response relationship was not observed for the majority of adverse events analyzed in the studies.

Phase III clinical trials of brivaracetam as adjunctive therapy in patients with refractory partial onset epilepsy are already underway. Nearly 1,300 epilepsy patients, ages 16-70, will take part in three multicenter, multinational phase III trials. Two randomized, double-blind, placebo- controlled studies are designed to evaluate the efficacy and safety of brivaracetam (5, 20 and 50 mg/day or 20, 50 and 100 mg/day) over 12 weeks in patients with partial onset epilepsy, no
'/>"/>

SOURCE UCB, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... and her research group at the DFG Research Center ... the TU Dresden (CRTD) demonstrated for the first time ... cord in three dimensions from mouse embryonic stem cells. ... interneurons along the dorsal/ventral axis was observed., This study ... " Stem Cell Reports " on 30.10.2014 ., For ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 Don Allred ... and health insurance plans for North Carolina residents, is ... office in Burlington’s Holly Hill Mall. The new branch ... agents already helping customers through all facets of the ... , Allred Insurance spokesman Scott Allred couldn’t be happier ...
(Date:10/30/2014)... October 30, 2014 Radio listeners who ... questions about the impact of traditional radio commercials and ... most likely to influence a purchasing decision. , Those ... 525 consumers conducted by radio marketing company CRN International. ... isolating the results of respondents who indicated they have ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 Dr. Joseph Furlin ... new website for his practices; OB GYN in Melrose ... . This website contains important information about each of ... well as downloadable patient forms in English and Spanish. ... the service pages on the website provide Dr. Furlin’s patients ...
(Date:10/30/2014)... The human brain is often overlooked ... to help maintain better mental health, according to Dr. ... Lose Your Memory in 100 Ways’ for just that ... conflicting attitudes to help keep the reader constantly thinking. ... must decipher the hidden logic within. , “If you ...
Breaking Medicine News(10 mins):Health News:Reconstruction of a patterned piece of spinal cord in 3-D culture 2Health News:Allred Insurance Satellite Office Grand Opening 2Health News:CRN Research On Radio Messaging Effectiveness Now Available In Four Specific Product Categories 2Health News:CRN Research On Radio Messaging Effectiveness Now Available In Four Specific Product Categories 3Health News:Dr. Joseph Furlin Launches New Website with Information about Care Services 2Health News:‘Dementia Express’ Offers Contradictory and Sometimes Reverse Thinking, All to Keep its Reader on Their Toes With an Active Mind. 2
... There has been a Dutch study which links diets ... E, and zinc to lower odds of developing age-related ... the study can be seen in The Journal of ... van Leeuwen, MD, PhD, and colleagues.,Age-related macular degeneration or ...
... of HIV in the three armed services, particularly the army, ... // for all its personnel serving in the northeast. ... insurgency-affected northeast as well as those returning from the region ... Singh, director general of the Armed Forces Medical Services (AFMS). ...
... pharmaceutical companies are keen to enhance business with India, ... the stringent visa norms. ,Pakistani firms are ... the Chinese, apart from the language barrier. ... though their rates are cheaper than the Indian market," ...
... colleagues, Feinberg School of Medicine have reported in Journal ... // reduces the cardio-respiratory fitness leading to increase in ... risk of cardiovascular diseases. The researchers conducted their survey ... 50 years and below 50 years of age and ...
... Researchers have found that obese people are in increased ... conducted by Professor Michael Belkin and Zohar Habot-Wilner // ... more than 20 reviews and found that risk of ... studies have proved the link between obesity and other ...
... system gets affected by rabies which is transmitted through the ... is required for a person who is bitten by a ... bite from an animal is unprovoked, it is safer to ... for the infection. If found infected, the animal has to ...
Cached Medicine News:Health News:Move to make HIV Tests mandatory For Soldiers In Northeast 2Health News:Pakistan drug companies seek trade ties with India 2
(Date:10/30/2014)... 30, 2014 Stryker Orthopaedics, the Official Joint ... is rounding out its debut year of the relationship ... Scottsdale, AZ. This marks the eleventh tournament ... that the brand has activated on-site with the "Stryker ... fans on the importance of joint health.  ...
(Date:10/30/2014)... , Oct. 30, 2014  Zimmer Holdings, Inc. (NYSE: ... the future executive leadership team and organizational structure of ... transaction.  Zimmer also announced that the combined organization will ... be named Zimmer Biomet, with the new brand to ... closing of the merger.  The future leadership team is ...
(Date:10/30/2014)... 2014   ViaDerma, Inc. (OTCQB: VDRM), ... products to market, has recently released a revolutionary ... a topical liquid tetracycline-based antibiotic that uses a ... oral medication active ingredients into topical drugs. The ... antibiotic to help prevent skin infection in minor ...
Breaking Medicine Technology:Stryker Mobility Zone Makes Final Stop Of 2014 At Charles Schwab Cup Championship 2Stryker Mobility Zone Makes Final Stop Of 2014 At Charles Schwab Cup Championship 3Stryker Mobility Zone Makes Final Stop Of 2014 At Charles Schwab Cup Championship 4Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 2Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 3Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 4Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 5Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 6Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 7Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 8Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 9ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 2ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 3
... ... ... ... ...
... ... ... ... ...
Cached Medicine Technology:DURECT and Nycomed Amend POSIDUR(TM) License Agreement to Separate Funding and Control of U.S. and E.U. Clinical Programs and to Expand Territory 2DURECT and Nycomed Amend POSIDUR(TM) License Agreement to Separate Funding and Control of U.S. and E.U. Clinical Programs and to Expand Territory 3DURECT and Nycomed Amend POSIDUR(TM) License Agreement to Separate Funding and Control of U.S. and E.U. Clinical Programs and to Expand Territory 4DURECT and Nycomed Amend POSIDUR(TM) License Agreement to Separate Funding and Control of U.S. and E.U. Clinical Programs and to Expand Territory 5DURECT and Nycomed Amend POSIDUR(TM) License Agreement to Separate Funding and Control of U.S. and E.U. Clinical Programs and to Expand Territory 6DURECT and Nycomed Amend POSIDUR(TM) License Agreement to Separate Funding and Control of U.S. and E.U. Clinical Programs and to Expand Territory 7Elsevier is Meeting Today's Medical Students' Needs With Online, Mobile and Print Tools 2Elsevier is Meeting Today's Medical Students' Needs With Online, Mobile and Print Tools 3Elsevier is Meeting Today's Medical Students' Needs With Online, Mobile and Print Tools 4Elsevier is Meeting Today's Medical Students' Needs With Online, Mobile and Print Tools 5Elsevier is Meeting Today's Medical Students' Needs With Online, Mobile and Print Tools 6Elsevier is Meeting Today's Medical Students' Needs With Online, Mobile and Print Tools 7Elsevier is Meeting Today's Medical Students' Needs With Online, Mobile and Print Tools 8Elsevier is Meeting Today's Medical Students' Needs With Online, Mobile and Print Tools 9Elsevier is Meeting Today's Medical Students' Needs With Online, Mobile and Print Tools 10Elsevier is Meeting Today's Medical Students' Needs With Online, Mobile and Print Tools 11
... is enzyme immunoassay kit for the ... concentration in serum. Enzyme immunoassay (EIA) ... many protein hormones in body fluids ... rapid and specific assay. This enzyme ...
SHIONORIA BNP,is a reagent used in the measurement of blood BNP. The blood BNP test allows accurate estimation of coronary functions....
... method for the semi-quantitative determination of ... human serum. The results of the ... an aid in the diagnosis of ... with elevated anti-neutrophil cytoplasmic antibodies (P-ANCA) ...
... The determination of Ang ... in monitoring the pharmacological effect ... variety of angiotensin converting enzyme ... II receptor antagonists as well ...
Medicine Products: